Determination of fluconazole in human plasma by micellar electrokinetic capillary chromatography with detection at 190 nm

被引:23
作者
vonHeeren, F [1 ]
Tanner, R [1 ]
Theurillat, R [1 ]
Thormann, W [1 ]
机构
[1] UNIV BERN,DEPT CLIN PHARMACOL,CH-3010 BERN,SWITZERLAND
关键词
fluconazole; micellar electrokinetic capillary chromatography; therapeutic drug monitoring;
D O I
10.1016/0021-9673(96)00189-6
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The determination of fluconazole (Diflucan) in human plasma by micellar electrokinetic capillary chromatography (MECC) with on-column UV absorption detection at 190 nm from primary, deproteinized and extracted plasma samples is discussed. Direct injection of plain plasma or of the supernatant after protein precipitation with acetonitrile is shown to permit the determination of fluconazole drug levels of >5 mu g/ml only. With liquid-liquid extraction employing dichloromethane, the detection Emit is about 1 mu g/ml. After extraction using disposable solid-phase C-18 cartridges and 1 ml of plasma, however, drug levels as low as 100 ng/ml can be determined unambiguously. Calibration graphs between 0.125-25.0 mu g/ml (seven data points) are shown to be linear, with a regression coefficient r>0.999. For fluconazole plasma levels of 5 mu g/ml, intra-day and inter-day imprecisions (n=10) are about 2 and 5%, respectively. Using the same solid-phase extraction procedure, 44 fluconazole plasma levels that were determined by MECC are shown to agree well with those obtained by HPLC and elucidated pharmacokinetic data compare well with those found in the literature. The advantages of using MECC instead of HPLC for the determination of fluconazole plasma levels and pharmacokinetics are the high resolution efficiency, low-cost capillary columns and the small consumption of inexpensive and environmentally friendly chemicals.
引用
收藏
页码:165 / 172
页数:8
相关论文
共 22 条
[1]   STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT [J].
BLAND, JM ;
ALTMAN, DG .
LANCET, 1986, 1 (8476) :307-310
[2]  
BRAMMER KW, 1990, REV INFECT DIS, V12, pS318
[3]  
*BRIT SOC ANT CHEM, 1991, LANCET, V337, P1577
[4]   DETERMINATION OF FLUCONAZOLE IN BIOLOGICAL-FLUIDS BY CAPILLARY COLUMN GAS-CHROMATOGRAPHY WITH A NITROGEN DETECTOR [J].
DEBRUYNE, D ;
RYCKELYNCK, JP ;
BIGOT, MC ;
MOULIN, M .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1988, 77 (06) :534-535
[5]  
DOC AG, 1995, ARZ SCHW, P495
[6]   DETERMINATION OF FLUCONAZOLE IN HUMAN SERUM BY SOLID-PHASE EXTRACTION AND REVERSED-PHASE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY [J].
INAGAKI, K ;
TAKAGI, J ;
LOR, E ;
OKAMOTO, MP ;
GILL, MA .
THERAPEUTIC DRUG MONITORING, 1992, 14 (04) :306-311
[7]  
LAZAR JD, 1990, REV INFECT DIS S3, V12, P327
[8]   DETERMINATION OF N-ACETYLATOR PHENOTYPE USING CAFFEINE AS A PROBE COMPOUND - A COMPARISON OF HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY AND CAPILLARY ELECTROPHORESIS METHODS [J].
LLOYD, DK ;
FRIED, K ;
WAINER, IW .
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1992, 578 (02) :283-291
[9]   SEPARATION AND DETERMINATION OF ASPOXICILLIN IN HUMAN PLASMA BY MICELLAR ELECTROKINETIC CHROMATOGRAPHY WITH DIRECT SAMPLE INJECTION [J].
NISHI, H ;
FUKUYAMA, T ;
MATSUO, M .
JOURNAL OF CHROMATOGRAPHY, 1990, 515 :245-255
[10]   FLUCONAZOLE - A NEW TRIAZOLE ANTIFUNGAL AGENT [J].
PASKO, MT ;
PISCITELLI, SC ;
VANSLOOTEN, AD .
DICP-THE ANNALS OF PHARMACOTHERAPY, 1990, 24 (09) :860-867